Lenacapavir highly effective against HIV, but distribution sparks equity concerns

Lenacapavir, a twice-a-year injection, has shown remarkable effectiveness in preventing HIV infection and distribution is now under way. However, questions are being raised about whether the drug will reach the communities and regions most in need. Experts warn that unequal access could significantly limit the global impact of this breakthrough medication.

Similar stories

🏥 Health Kenya, Uganda and South Africa to manufacture next-gen HIV prevention medicines locally The Independent World · 9d ago 🏥 Health 99% effective HIV drug exists, but USAID cuts block global access The Guardian Health · 12d ago 🏥 Health HIV funding drops to lowest level since 2007 amid Trump aid cuts The Independent World · 15d ago